Vesting of Long Term Incentive Plan Awards

RNS Number : 4475A

Craneware plc

23 September 2022

 

Craneware plc

("Craneware" or the "Company")

Vesting of Long Term Incentive Plan Awards

23 September 2022 - The Board of Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that on 21 September 2022 , under the terms of the Craneware plc Long Term Incentive Plan (2016) ("LTIP"), conditional awards of ordinary shares of 1p each in the Company ("Shares") which were granted to three Directors of the Company, vested to the extent that certain performance conditions were satisfied. 

Director	Date of grant of conditional share award	Net amount of Shares received from conditional share awards vested on 21 September 2022	Percentage of issued share capital of the Company
Keith Neilson (CEO)	5 September 2018	1,901
	4 September 2019	4,217
		________
		Total 6,118	0.017%
		________
Craig Preston (CFO)	5 September 2018	1,408
	4 September 2019	3,135
		________
		Total 4,543	0.013%
		________
Isabel Urquhart (CPO)	4 September 2019	1,723	0.005%

The net amount of Shares received by each of the Directors from the vested LTIP awards was after payment of the associated tax liabilities. No consideration was payable by each of the Directors to receive the Shares from these LTIP awards.

Following this transaction, Keith Neilson holds 3,440,304 Shares which is 9.68% of the issued share capital of the Company, Craig Preston holds 93,872 Shares which is 0.26% of the issued share capital of the Company and Isabel Urquhart holds 8,300 Shares which is 0.02% of the issued share capital of the Company. 

PDMR notification: Keith Neilson

1.  Details of the Restricted Person / person closely associated with him or her

a) Name  Keith Neilson

2.  Reason for the notification

a) Position / status  CEO

b) Initial notification / Amendment  Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name  Craneware plc

b) LEI  213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument    Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code    ISIN GB00B2425G68

c) Nature of the transaction  Vesting of conditional share awards under the  Craneware plc Long Term Incentive Plan (2016)

d) Price(s) and volume(s)    Volume(s) released from vested awards 6,118 ,

 Price(s) £0

e) Aggregated information:

  i. Aggregated volume      Aggregate volume released 6,118

  ii. Price      Price(s) £0

f) Date of the transaction     2022-09-21

g) Place of the transaction    Outside a trading venue

PDMR notification: Craig Preston

1.  Details of the Restricted Person / person closely associated with him or her

a) Name  Craig Preston

2.  Reason for the notification

a) Position / status  CFO

b) Initial notification / Amendment  Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name  Craneware plc

b) LEI  213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument  Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code  ISIN GB00B2425G68

c) Nature of the transaction  Vesting of conditional share awards under the Craneware plc

  Long Term Incentive Plan (2016)

d) Price(s) and volume(s)  Volume(s) released from vested awards 4,543 , Price(s) £0

e) Aggregated information:

  i. Aggregated volume  Aggregate volume released 4,543

  ii. Price  Price(s) £0

f) Date of the transaction    2022-09-21

g) Place of the transaction  Outside a trading venue

PDMR notification: Isabel Urquhart

1.  Details of the Restricted Person / person closely associated with him or her

a) Name  Isabel Urquhart

2.  Reason for the notification

a) Position / status  Chief People Officer

b) Initial notification / Amendment  Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name    Craneware plc

b) LEI  213800O2CTJ1YFXNXG05

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument  Ordinary shares of 1p each in the capital of Craneware plc

b) Identification code  ISIN GB00B2425G68

c) Nature of the transaction  Vesting of conditional share award under the Craneware plc

    Long Term Incentive Plan (2016)

d) Price(s) and volume(s)  Volume(s) released from vested award 1,723 , Price(s) £0

e) Aggregated information:

  i. Aggregated volume  Aggregate volume released 1,723

  ii. Price  Price(s) £0

f) Date of the transaction    2022-09-21

g) Place of the transaction  Outside a trading venue

For further information, please contact:

Craneware plc   [phone]

Keith Neilson, CEO

Craig Preston, CFO

Alma (Financial PR)   [phone]

Caroline Forde, Hilary Buchanan, Joe Pederzolli  [e-mail]

Peel Hunt (NOMAD and Joint Broker)   [phone]

Dan Webster, Andrew Clark

Investec Bank PLC (Joint Broker)   [phone]

Patrick Robb, Henry Reast, Sebastian Lawrence

Berenberg (Joint Broker)   [phone]

Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff

About Craneware

We at The Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organisations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for US healthcare providers.

Our combined suite of applications and industry-leading team of experts help our customers contextualise operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence- something no other single partner can provide.

Together, approximately 40% of registered U.S. hospitals are now our customers, including more than 12,000 US hospitals, health systems and affiliated retail pharmacies and clinics. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.

Learn more at www.thecranewaregroup.com

 

END

 

 

MSCVXLBLLKLBBBL